19 results on '"Potez M"'
Search Results
2. O058 - FLASH Modalities Track (Oral Presentations) DOUBLE-FRACTION SYNCHROTRON MICROBEAM RADIATION OF MURINE MELANOMA IMPROVES LOCAL CONTROL AND TRIGGERS REGRESSION OF LOCOREGIONAL METASTASIS
- Author
-
Martin, O., Trappetti, V., Potez, M., Fernandez-Palomo, C., Volarevic, V., Pellicioli, P., Fazzari, J., Krisch, M., and Djonov, V.
- Published
- 2022
- Full Text
- View/download PDF
3. Synchrotron x-ray microtransections: a new treatment for epileptic seizures arising from eloquent cortical areas
- Author
-
Pouyatos, B., Nemoz, C., Chabrol, T., Potez, M., Bräuer, E., Renaud, Luc, Pernet-Gallay, Karin, Estève, F., David, O., Kahane, P., Laissue, J.A., Depaulis, A., Serduc, R., SynapCell SAS, Grenoble Institut des Neurosciences (GIN), Université Joseph Fourier - Grenoble 1 (UJF)-Institut National de la Santé et de la Recherche Médicale (INSERM), European Synchrotron Radiation Facility (ESRF), Centre d'exploration Fonctionnelle et de Formation (CE2F), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Laboratoire de physiopathologie de l'épilepsie (LNPEE), CHU Grenoble, Pathology Institute, and University of Bern
- Subjects
[PHYS.PHYS.PHYS-MED-PH]Physics [physics]/Physics [physics]/Medical Physics [physics.med-ph] - Abstract
International audience; Synchrotron-generated X-ray (SRX) microbeams deposit high doses to submillimetric targets whilst minimizing irradiation of neighboring healthy tissue. We developed a new radiosurgical method which demonstrably transects cortical brain tissue without affecting adjacent regions. This non-invasive method mimicks surgical multiple subpial transections and similarly prevents epileptic seizure propagation into non-resectable and/or eloquent brain regions. We made such image-guided microtransections in the left somatosensory cortex in a rat model of generalized epilepsy using high interlaced radiation doses (820Gy) in thin (200µm) parallel slices of tissue. This procedure, targeting the brain volume from which seizures arise, altered the horizontal propagation of abnormal neuronal activities for 9 weeks, as evidenced by a decrease of seizure power and the coherence between tissue slices in comparison to the contralateral cortex. The brain tissue sited between transections stayed functionally and histologically normal, while the irradiated micro-slices remained devoid of myelin and neurons two months after irradiation. This pre-clinical proof of concept highlights the translational potential of non-invasive SRX transections for treating epilepsies that are not eligible for resective surgery.
- Published
- 2015
4. Synchrotron X-ray microtransections: a non invasive approach for epileptic seizures arising from eloquent cortical areas
- Author
-
Pouyatos, B., primary, Nemoz, C., additional, Chabrol, T., additional, Potez, M., additional, Bräuer, E., additional, Renaud, L., additional, Pernet-Gallay, K., additional, Estève, F., additional, David, O., additional, Kahane, P., additional, Laissue, J. A., additional, Depaulis, A., additional, and Serduc, R., additional
- Published
- 2016
- Full Text
- View/download PDF
5. Microbeam Radiation Therapy Opens a Several Days' Vessel Permeability Window for Small Molecules in Brain Tumor Vessels.
- Author
-
Potez M, Rome C, Lemasson B, Heemeryck P, Laissue JA, Stupar V, Mathieu H, Collomb N, Barbier EL, Djonov V, and Bouchet A
- Subjects
- Animals, Rats, Gadolinium pharmacokinetics, Time Factors, Male, Immunoglobulin G, Albumins metabolism, Albumins pharmacokinetics, Glioma radiotherapy, Glioma blood supply, Glioma metabolism, Glioma diagnostic imaging, Glioma pathology, Radiotherapy Dosage, Heterocyclic Compounds, Brain Neoplasms radiotherapy, Brain Neoplasms blood supply, Brain Neoplasms diagnostic imaging, Brain Neoplasms metabolism, Brain Neoplasms pathology, Capillary Permeability radiation effects, Blood-Brain Barrier metabolism, Blood-Brain Barrier radiation effects, Synchrotrons, Rats, Inbred F344, Magnetic Resonance Imaging methods, Organometallic Compounds pharmacokinetics, Contrast Media pharmacokinetics
- Abstract
Purpose: Synchrotron microbeam radiation therapy (MRT), based on an inhomogeneous geometric and microscopic irradiation pattern of the tissues with high-dose and high-dose-rate x-rays, enhances the permeability of brain tumor vessels. This study attempted to determine the time and size range of the permeability window induced by MRT in the blood-brain (tumor) barrier., Methods and Materials: Rats-bearing 9L gliomas were exposed to MRT, either unidirectional (tumor dose, 406 Gy) or bidirectional (crossfired) (2 × 203 Gy). We measured vessel permeability to molecules of 3 sizes (Gd-DOTA, Dotarem, 0.56 kDa; gadolinium-labeled albumin, ∼74 kDa; and gadolinium-labeled IgG, 160 kDa) by daily in vivo magnetic resonance imaging, from 1 day before to 10 days after irradiation., Results: An equivalent tumor dose of bidirectional MRT delivered from 2 orthogonal directions increased tumor vessel permeability for the smallest molecule tested more effectively than unidirectional MRT. Bidirectional MRT also affected the permeability of normal contralateral vessels to a different extent than unidirectional MRT. Conversely, bidirectional MRT did not modify the permeability of normal or tumor vessels for both larger molecules (74 and 160 kDa)., Conclusions: High-dose bidirectional (cross-fired) MRT induced a significant increase in tumor vessel permeability for small molecules between the first and the seventh day after irradiation, whereas permeability of vessels in normal brain tissue remained stable. Such a permeability window could facilitate an efficient and safe delivery of intravenous small molecules (≤0.56 kDa) to tumoral tissues. A permeability window was not achieved by molecules larger than gado-grafted albumin (74 kDa). Vascular permeability for molecules between these 2 sizes has not been determined., (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
6. Neutralizing Antibody Response following a Third Dose of the mRNA-1273 Vaccine among Cancer Patients.
- Author
-
Dukes CW, Potez M, Lancet J, Kuter BJ, Whiting J, Mo Q, Leav B, Wang H, Vanas JS, Cubitt CL, Isaacs-Soriano K, Kennedy K, Rathwell J, Diaz Cobo J, O'Nan W, Sirak B, Dong N, Tan E, Hwu P, Giuliano AR, and Pilon-Thomas S
- Abstract
Cancer patients are at an increased risk of morbidity and mortality from SARS-CoV-2 infection and have a decreased immune response to vaccination. We conducted a study measuring both the neutralizing and total antibodies in cancer patients following a third dose of the mRNA-1273 COVID-19 vaccine. Immune responses were measured with an enzyme-linked immunosorbent assay (ELISA) and neutralization assays. Kruskal-Wallis tests were used to evaluate the association between patient characteristics and neutralization geometric mean titers (GMTs), and paired t -tests were used to compare the GMTs between different timepoints. Spearman correlation coefficients were calculated to determine the correlation between total antibody and neutralization GMTs. Among 238 adults diagnosed with cancer, a third dose of mRNA-1273 resulted in a 37-fold increase in neutralization GMT 28 days post-vaccination and maintained a 14.6-fold increase at 6 months. Patients with solid tumors or lymphoid cancer had the highest and lowest neutralization GMTs, respectively, at both 28 days and 6 months post-dose 3. While total antibody GMTs in lymphoid patients continued to increase, other cancer types showed decreases in titers between 28 days and 6 months post-dose 3. A strong correlation ( p < 0.001) was found between total antibody and neutralization GMTs. The third dose of mRNA-1273 was able to elicit a robust neutralizing antibody response in cancer patients, which remained for 6 months after administration. Lymphoid cancer patients can benefit most from this third dose, as it was shown to continue to increase total antibody GMTs 6 months after vaccination.
- Published
- 2023
- Full Text
- View/download PDF
7. Glioblastoma Stem Cell Targeting Peptide Isolated Through Phage Display Binds Cadherin 2.
- Author
-
Kim J, Potez M, She C, Huang P, Wu Q, Bao S, Rich JN, and Liu JKC
- Subjects
- Neoplastic Stem Cells, Humans, Animals, Mice, Neoplasm Transplantation, Molecular Targeted Therapy, Disease Models, Animal, Glioblastoma drug therapy, Glioblastoma pathology, Cell Surface Display Techniques, Peptides therapeutic use, Cadherins antagonists & inhibitors
- Abstract
Glioblastoma stem cells (GSCs) have unique properties of self-renewal and tumor initiation that make them potential therapeutic targets. Development of effective therapeutic strategies against GSCs requires both specificity of targeting and intracranial penetration through the blood-brain barrier. We have previously demonstrated the use of in vitro and in vivo phage display biopanning strategies to isolate glioblastoma targeting peptides. Here we selected a 7-amino acid peptide, AWEFYFP, which was independently isolated in both the in vitro and in vivo screens and demonstrated that it was able to target GSCs over differentiated glioma cells and non-neoplastic brain cells. When conjugated to Cyanine 5.5 and intravenously injected into mice with intracranially xenografted glioblastoma, the peptide localized to the site of the tumor, demonstrating intracranial tumor targeting specificity. Immunoprecipitation of the peptide with GSC proteins revealed Cadherin 2 as the glioblastoma cell surface receptor targeted by the peptides. Peptide targeting of Cadherin 2 on GSCs was confirmed through ELISA and in vitro binding analysis. Interrogation of glioblastoma databases demonstrated that Cadherin 2 expression correlated with tumor grade and survival. These results confirm that phage display can be used to isolate unique tumor-targeting peptides specific for glioblastoma. Furthermore, analysis of these cell specific peptides can lead to the discovery of cell specific receptor targets that may serve as the focus of future theragnostic tumor-homing modalities for the development of precision strategies for the treatment and diagnosis of glioblastomas., (© The Author(s) 2023. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
8. Use of phage display biopanning as a tool to design CAR-T cells against glioma stem cells.
- Author
-
Potez M, Snedal S, She C, Kim J, Thorner K, Tran TH, Ramello MC, Abate-Daga D, and Liu JKC
- Abstract
Background: Glioblastoma (GBM) is both the most common and aggressive type of primary brain tumor, associated with high mortality rates and resistance to conventional therapy. Despite recent advancements in knowledge and molecular profiling, recurrence of GBM is nearly inevitable. This recurrence has been attributed to the presence of glioma stem cells (GSCs), a small fraction of cells resistant to standard-of-care treatments and capable of self-renewal and tumor initiation. Therefore, targeting these cancer stem cells will allow for the development of more effective therapeutic strategies against GBM. We have previously identified several 7-amino acid length peptides which specifically target GSCs through in vitro and in vivo phage display biopanning., Methods and Results: We have combined two of these peptides to create a dual peptide construct (EV), and demonstrated its ability to bind GSCs in vitro and target intracranial GBM in mouse models. A peptide pull-down performed with peptide EV followed by mass spectrometry determined N-cadherin as the binding partner of the peptide, which was validated by enzyme-linked immunosorbent assay and surface plasmon resonance. To develop cytotoxic cellular products aimed at specifically targeting GSCs, chimeric antigen receptors (CARs) were engineered containing the peptide EV in place of the single-chain variable fragment (scFv) as the antigen-binding domain. EV CAR-transduced T cells demonstrated specific reactivity towards GSCs by production of interferon-gamma when exposed to GSCs, in addition to the induction of GSC-specific apoptosis as illustrated by Annexin-V staining., Conclusion: These results exemplify the use of phage display biopanning for the isolation of GSC-targeting peptides, and their potential application in the development of novel cytotoxic therapies for GBM., Competing Interests: DA-D and JL are inventors or co-inventors in several patents and patent applications filed by the Moffitt Cancer Center, including one pertaining to this work US 11384118. DA-D also receives or has received funding from Intellia and bluebird bio/2-seventy bio, but neither of these relationships are associated with the subject matter of this manuscript. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Potez, Snedal, She, Kim, Thorner, Tran, Ramello, Abate-Daga and Liu.)
- Published
- 2023
- Full Text
- View/download PDF
9. Microbeam Radiation Therapy Controls Local Growth of Radioresistant Melanoma and Treats Out-of-Field Locoregional Metastasis.
- Author
-
Trappetti V, Potez M, Fernandez-Palomo C, Volarevic V, Shintani N, Pellicioli P, Ernst A, Haberthür D, Fazzari JM, Krisch M, Laissue JA, Anderson RL, Martin OA, and Djonov VG
- Subjects
- Animals, Cytokines, Mice, Mice, Inbred C57BL, Syndrome, T-Lymphocytes, Melanoma radiotherapy, Synchrotrons
- Abstract
Purpose: Synchrotron-generated microbeam radiation therapy (MRT) represents an innovative preclinical type of cancer radiation therapy with an excellent therapeutic ratio. Beyond local control, metastatic spread is another important endpoint to assess the effectiveness of radiation therapy treatment. Currently, no data exist on an association between MRT and metastasis. Here, we evaluated the ability of MRT to delay B16F10 murine melanoma progression and locoregional metastatic spread., Methods and Materials: We assessed the primary tumor response and the extent of metastasis in sentinel lymph nodes in 2 cohorts of C57BL/6J mice, one receiving a single MRT and another receiving 2 MRT treatments delivered with a 10-day interval. We compared these 2 cohorts with synchrotron broad beam-irradiated and nonirradiated mice. In addition, using multiplex quantitative platforms, we measured plasma concentrations of 34 pro- and anti-inflammatory cytokines and frequencies of immune cell subsets infiltrating primary tumors that received either 1 or 2 MRT treatments., Results: Two MRT treatments were significantly more effective for local control than a single MRT. Remarkably, the second MRT also triggered a pronounced regression of out-of-radiation field locoregional metastasis. Augmentation of CXCL5, CXCL12, and CCL22 levels after the second MRT indicated that inhibition of melanoma progression could be associated with increased activity of antitumor neutrophils and T-cells. Indeed, we demonstrated elevated infiltration of neutrophils and activated T-cells in the tumors after the second MRT., Conclusions: Our study highlights the importance of monitoring metastasis after MRT and provides the first MRT fractionation schedule that promotes local and locoregional control with the potential to manage distant metastasis., (Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
10. Targeted Accumulation of Macrophages Induced by Microbeam Irradiation in a Tissue-Dependent Manner.
- Author
-
Trappetti V, Fazzari J, Fernandez-Palomo C, Smyth L, Potez M, Shintani N, de Breuyn Dietler B, Martin OA, and Djonov V
- Abstract
Radiation therapy (RT) is a vital component of multimodal cancer treatment, and its immunomodulatory effects are a major focus of current therapeutic strategies. Macrophages are some of the first cells recruited to sites of radiation-induced injury where they can aid in tissue repair, propagate radiation-induced fibrogenesis and influence tumour dynamics. Microbeam radiation therapy (MRT) is a unique, spatially fractionated radiation modality that has demonstrated exceptional tumour control and reduction in normal tissue toxicity, including fibrosis. We conducted a morphological analysis of MRT-irradiated normal liver, lung and skin tissues as well as lung and melanoma tumours. MRT induced distinct patterns of DNA damage, reflecting the geometry of the microbeam array. Macrophages infiltrated these regions of peak dose deposition at variable timepoints post-irradiation depending on the tissue type. In normal liver and lung tissue, macrophages clearly demarcated the beam path by 48 h and 7 days post-irradiation, respectively. This was not reflected, however, in normal skin tissue, despite clear DNA damage marking the beam path. Persistent DNA damage was observed in MRT-irradiated lung carcinoma, with an accompanying geometry-specific influx of mixed M1/M2-like macrophage populations. These data indicate the unique potential of MRT as a tool to induce a remarkable accumulation of macrophages in an organ/tissue-specific manner. Further characterization of these macrophage populations is warranted to identify their organ-specific roles in normal tissue sparing and anti-tumour responses.
- Published
- 2022
- Full Text
- View/download PDF
11. Phage display targeting identifies EYA1 as a regulator of glioblastoma stem cell maintenance and proliferation.
- Author
-
Kim J, She C, Potez M, Huang P, Wu Q, Prager BC, Qiu Z, Bao S, Rich JN, and Liu JKC
- Subjects
- Cell Line, Tumor, Cell Proliferation, Humans, Intracellular Signaling Peptides and Proteins genetics, Intracellular Signaling Peptides and Proteins metabolism, Neoplastic Stem Cells metabolism, Nuclear Proteins genetics, Nuclear Proteins metabolism, Protein Tyrosine Phosphatases genetics, Protein Tyrosine Phosphatases metabolism, Bacteriophages metabolism, Brain Neoplasms pathology, Glioblastoma pathology
- Abstract
Glioblastoma (GBM) ranks among the most lethal of human malignancies with GBM stem cells (GSCs) that contribute to tumor growth and therapeutic resistance. Identification and isolation of GSCs continue to be a challenge, as definitive methods to purify these cells for study or targeting are lacking. Here, we leveraged orthogonal in vitro and in vivo phage display biopanning strategies to isolate a single peptide with GSC-specific binding properties. In silico analysis of this peptide led to the isolation of EYA1 (Eyes Absent 1), a tyrosine phosphatase and transcriptional coactivator. Validating the phage discovery methods, EYA1 was preferentially expressed in GSCs compared to differentiated tumor progeny. MYC is a central mediator of GSC maintenance but has been resistant to direct targeting strategies. Based on correlation and colocalization of EYA1 and MYC, we interrogated a possible interaction, revealing binding of EYA1 to MYC and loss of MYC expression upon targeting EYA1. Supporting a functional role for EYA1, targeting EYA1 expression decreased GSC proliferation, migration, and self-renewal in vitro and tumor growth in vivo. Collectively, our results suggest that phage display can identify novel therapeutic targets in stem-like tumor cells and that an EYA1-MYC axis represents a potential therapeutic paradigm for GBM., (©AlphaMed Press 2021.)
- Published
- 2021
- Full Text
- View/download PDF
12. Complete Remission of Mouse Melanoma after Temporally Fractionated Microbeam Radiotherapy.
- Author
-
Fernandez-Palomo C, Trappetti V, Potez M, Pellicioli P, Krisch M, Laissue J, and Djonov V
- Abstract
Background: Synchrotron Microbeam Radiotherapy (MRT) significantly improves local tumour control with minimal normal tissue toxicity. MRT delivers orthovoltage X-rays at an ultra-high "FLASH" dose rate in spatially fractionated beams, typically only few tens of micrometres wide. One of the biggest challenges in translating MRT to the clinic is its use of high peak doses, of around 300-600 Gy, which can currently only be delivered by synchrotron facilities. Therefore, in an effort to improve the translation of MRT to the clinic, this work studied whether the temporal fractionation of traditional MRT into several sessions with lower, more clinically feasible, peak doses could still maintain local tumour control., Methods: Two groups of twelve C57Bl/6J female mice harbouring B16-F10 melanomas in their ears were treated with microbeams of 50 µm in width spaced by 200 µm from their centres. The treatment modality was either (i) a single MRT session of 401.23 Gy peak dose (7.40 Gy valley dose, i.e., dose between beams), or (ii) three MRT sessions of 133.41 Gy peak dose (2.46 Gy valley dose) delivered over 3 days in different anatomical planes, which intersected at 45 degrees. The mean dose rate was 12,750 Gy/s, with exposure times between 34.2 and 11.4 ms, respectively., Results: Temporally fractionated MRT ablated 50% of B16-F10 mouse melanomas, preventing organ metastases and local tumour recurrence for 18 months. In the rest of the animals, the median survival increased by 2.5-fold in comparison to the single MRT session and by 4.1-fold with respect to untreated mice., Conclusions: Temporally fractionating MRT with lower peak doses not only maintained tumour control, but also increased the efficacy of this technique. These results demonstrate that the solution to making MRT more clinically feasible is to irradiate with several fractions of intersecting arrays with lower peak doses. This provides alternatives to synchrotron sources where future microbeam radiotherapy could be delivered with less intense radiation sources.
- Published
- 2020
- Full Text
- View/download PDF
13. Synchrotron X-Ray Boost Delivered by Microbeam Radiation Therapy After Conventional X-Ray Therapy Fractionated in Time Improves F98 Glioma Control.
- Author
-
Potez M, Bouchet A, Flaender M, Rome C, Collomb N, Grotzer M, Krisch M, Djonov V, Balosso J, Brun E, Laissue JA, and Serduc R
- Subjects
- Animals, Brain Neoplasms diagnostic imaging, Brain Neoplasms pathology, Cell Cycle radiation effects, Cell Proliferation radiation effects, Glioblastoma diagnostic imaging, Glioblastoma pathology, Magnetic Resonance Imaging, Male, Rats, Rats, Wistar, Tumor Burden radiation effects, Brain Neoplasms radiotherapy, Dose Fractionation, Radiation, Glioblastoma radiotherapy, Glioma radiotherapy, Synchrotrons, X-Ray Therapy instrumentation
- Abstract
Purpose: Synchrotron microbeam radiation therapy (MRT) is based on the spatial fractionation of the incident, highly collimated synchrotron beam into arrays of parallel microbeams depositing several hundred grays. It appears relevant to combine MRT with a conventional treatment course, preparing a treatment scheme for future patients in clinical trials. The efficiency of MRT delivered after several broad-beam (BB) fractions to palliate F98 brain tumors in rats in comparison with BB fractions alone was evaluated in this study., Methods and Materials: Rats bearing 10
6 F98 cells implanted in the caudate nucleus were irradiated by 5 fractions in BB mode (3 × 6 Gy + 2 × 8 Gy BB) or by 2 boost fractions in MRT mode to a total of 5 fractions (3 × 6 Gy BB + MRT 2 × 8 Gy valley dose; peak dose 181 Gy [50/200 μm]). Tumor growth was evaluated in vivo by magnetic resonance imaging follow-up at T-1 , T7 , T12 , T15 , T20 , and T25 days after radiation therapy and by histology and flow cytometry., Results: MRT-boosted tumors displayed lower cell density and cell proliferation compared with BB-irradiated tumors. The MRT boost completely stopped tumor growth during ∼4 weeks and led to a significant increase in median survival time, whereas tumors treated with BB alone recurred within a few days after the last radiation fraction., Conclusions: The first evidence is presented that MRT, delivered as a boost of conventionally fractionated irradiation by orthovoltage broad x-ray beams, is feasible and more efficient than conventional radiation therapy alone., (Copyright © 2020 Elsevier Inc. All rights reserved.)- Published
- 2020
- Full Text
- View/download PDF
14. Synchrotron Microbeam Radiation Therapy as a New Approach for the Treatment of Radioresistant Melanoma: Potential Underlying Mechanisms.
- Author
-
Potez M, Fernandez-Palomo C, Bouchet A, Trappetti V, Donzelli M, Krisch M, Laissue J, Volarevic V, and Djonov V
- Subjects
- Animals, Cell Proliferation radiation effects, Cellular Senescence, Ear Neoplasms blood supply, Ear Neoplasms metabolism, Ear Neoplasms pathology, Female, Melanoma, Experimental blood supply, Melanoma, Experimental chemistry, Melanoma, Experimental pathology, Mice, Mice, Inbred C57BL, Monocyte Chemoattractant Proteins metabolism, Staining and Labeling, Tumor Burden, Tumor Microenvironment, beta-Galactosidase, Ear Neoplasms radiotherapy, Melanoma, Experimental radiotherapy, Radiation Tolerance, Synchrotrons
- Abstract
Purpose: Synchrotron microbeam radiation therapy (MRT) is a method that spatially distributes the x-ray beam into several microbeams of very high dose (peak dose), regularly separated by low-dose intervals (valley dose). MRT selectively spares normal tissues, relative to conventional (uniform broad beam [BB]) radiation therapy., Methods and Materials: To evaluate the effect of MRT on radioresistant melanoma, B16-F10 murine melanomas were implanted into mice ears. Tumors were either treated with MRT (407.6 Gy peak; 6.2 Gy valley dose) or uniform BB irradiation (6.2 Gy)., Results: MRT induced significantly longer tumor regrowth delay than did BB irradiation. A significant 24% reduction in blood vessel perfusion was observed 5 days after MRT, and the cell proliferation index was significantly lower in melanomas treated by MRT compared with BB. MRT provoked a greater induction of senescence in melanoma cells. Bio-Plex analyses revealed enhanced concentration of monocyte-attracting chemokines in the MRT group: MCP-1 at D5, MIP-1α, MIP-1β, IL12p40, and RANTES at D9. This was associated with leukocytic infiltration at D9 after MRT, attributed mainly to CD8 T cells, natural killer cells, and macrophages., Conclusions: In light of its potential to disrupt blood vessels that promote infiltration of the tumor by immune cells and its induction of senescence, MRT could be a new therapeutic approach for radioresistant melanoma., (Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
15. Characterization of a B16-F10 melanoma model locally implanted into the ear pinnae of C57BL/6 mice.
- Author
-
Potez M, Trappetti V, Bouchet A, Fernandez-Palomo C, Güç E, Kilarski WW, Hlushchuk R, Laissue J, and Djonov V
- Subjects
- Animals, Cell Line, Tumor, Cell Proliferation, Ear Auricle, Female, Lymphangiogenesis, Lymphatic Metastasis immunology, Lymphatic Metastasis pathology, Macrophages immunology, Macrophages pathology, Melanoma, Experimental blood supply, Melanoma, Experimental secondary, Mice, Mice, Inbred C57BL, Neoplasm Transplantation methods, Neovascularization, Pathologic, Skin Neoplasms blood supply, Skin Neoplasms immunology, T-Lymphocytes immunology, T-Lymphocytes pathology, Melanoma, Experimental pathology, Skin Neoplasms pathology
- Abstract
The common experimental use of B16-F10 melanoma cells focuses on exploring their metastatic potential following intravenous injection into mice. In this study, B16-F10 cells are used to develop a primary tumor model by implanting them directly into the ears of C57BL/6J mice. The model represents a reproducible and easily traceable tool for local tumor growth and for making additional in vivo observations, due to the localization of the tumors. This model is relatively simple and involves (i) surgical opening of the ear skin, (ii) removal of a square-piece of cartilage followed by (iii) the implantation of tumor cells with fibrin gel. The remodeling of the fibrin gel within the cartilage chamber, accompanying tumor proliferation, results in the formation of blood vessels, lymphatics and tissue matrix that can be readily distinguished from the pre-existing skin structures. Moreover, this method avoids the injection-enforced artificial spread of cells into the pre-existing lymphatic vessels. The tumors have a highly reproducible exponential growth pattern with a tumor doubling time of around 1.8 days, reaching an average volume of 85mm3 16 days after implantation. The melanomas are densely cellular with proliferative indices of between 60 and 80%. The induced angiogenesis and lymphangiogenesis resulted in the development of well-vascularized tumors. Different populations of immunologically active cells were also present in the tumor; the population of macrophages decreases with time while the population of T cells remained quasi constant. The B16-F10 tumors in the ear frequently metastasized to the cervical lymph nodes, reaching an incidence of 75% by day 16. This newly introduced B16-F10 melanoma model in the ear is a powerful tool that provides a new opportunity to study the local tumor growth and metastasis, the associated angiogenesis, lymphangiogenesis and tumor immune responses. It could potentially be used to test different treatment strategies., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2018
- Full Text
- View/download PDF
16. Effects of Synchrotron X-Ray Micro-beam Irradiation on Normal Mouse Ear Pinnae.
- Author
-
Potez M, Bouchet A, Wagner J, Donzelli M, Bräuer-Krisch E, Hopewell JW, Laissue J, and Djonov V
- Subjects
- Animals, Dose-Response Relationship, Radiation, Ear pathology, Female, Mice, Mice, Inbred C57BL, Organ Specificity, Radiation Injuries, Experimental pathology, Time Factors, Ear radiation effects, Radiation Injuries, Experimental etiology, Synchrotrons, X-Ray Therapy adverse effects, X-Ray Therapy instrumentation
- Abstract
Purpose: To analyze the effects of micro-beam irradiation (MBI) on the normal tissues of the mouse ear., Methods and Materials: Normal mouse ears are a unique model, which in addition to skin contain striated muscles, cartilage, blood and lymphatic vessels, and few hair follicles. This renders the mouse ear an excellent model for complex tissue studies. The ears of C57BL6 mice were exposed to MBI (50-μm-wide micro-beams, spaced 200 μm between centers) with peak entrance doses of 200, 400, or 800 Gy (at ultra-high dose rates). Tissue samples were examined histopathologically, with conventional light and electron microscopy, at 2, 7, 15, 30, and 240 days after irradiation (dpi). Sham-irradiated animals acted as controls., Results: Only an entrance dose of 800 Gy caused a significant increase in the thickness of both epidermal and dermal ear compartments seen from 15 to 30 dpi; the number of sebaceous glands was significantly reduced by 30 dpi. The numbers of apoptotic bodies and infiltrating leukocytes peaked between 15 and 30 dpi. Lymphatic vessels were prominently enlarged at 15 up to 240 dpi. Sarcomere lesions in striated muscle were observed after all doses, starting from 2 dpi; scar tissue within individual beam paths remained visible up to 240 dpi. Cartilage and blood vessel changes remained histologically inconspicuous., Conclusions: Normal tissues such as skin, cartilage, and blood and lymphatic vessels are highly tolerant to MBI after entrance doses up to 400 Gy. The striated muscles appeared to be the most sensitive to MBI. Those findings should be taken into consideration in future micro-beam radiation therapy treatment schedules., (Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
17. Permeability of Brain Tumor Vessels Induced by Uniform or Spatially Microfractionated Synchrotron Radiation Therapies.
- Author
-
Bouchet A, Potez M, Coquery N, Rome C, Lemasson B, Bräuer-Krisch E, Rémy C, Laissue J, Barbier EL, Djonov V, and Serduc R
- Subjects
- Animals, Blood Volume, Blood-Brain Barrier diagnostic imaging, Blood-Brain Barrier physiopathology, Brain blood supply, Brain radiation effects, Brain Edema diagnostic imaging, Brain Neoplasms diagnostic imaging, Brain Neoplasms pathology, Capillary Permeability physiology, Cerebrovascular Circulation physiology, Dose Fractionation, Radiation, Glioma diagnostic imaging, Glioma pathology, Magnetic Resonance Imaging, Male, Monte Carlo Method, Oxygen Consumption, Random Allocation, Rats, Rats, Inbred F344, Time Factors, Tumor Burden, Blood-Brain Barrier radiation effects, Brain Neoplasms blood supply, Brain Neoplasms radiotherapy, Capillary Permeability radiation effects, Glioma blood supply, Glioma radiotherapy, Synchrotrons
- Abstract
Purpose: To compare the blood-brain barrier permeability changes induced by synchrotron microbeam radiation therapy (MRT, which relies on spatial fractionation of the incident x-ray beam into parallel micron-wide beams) with changes induced by a spatially uniform synchrotron x-ray radiation therapy., Methods and Materials: Male rats bearing malignant intracranial F98 gliomas were randomized into 3 groups: untreated, exposed to MRT (peak and valley dose: 241 and 10.5 Gy, respectively), or exposed to broad beam irradiation (BB) delivered at comparable doses (ie, equivalent to MRT valley dose); both applied by 2 arrays, intersecting orthogonally the tumor region. Vessel permeability was monitored in vivo by magnetic resonance imaging 1 day before (T
-1 ) and 1, 2, 7, and 14 days after treatment start. To determine whether physiologic parameters influence vascular permeability, we evaluated vessel integrity in the tumor area with different values for cerebral blood flow, blood volume, edema, and tissue oxygenation., Results: Microbeam radiation therapy does not modify the vascular permeability of normal brain tissue. Microbeam radiation therapy-induced increase of tumor vascular permeability was detectable from T2 with a maximum at T7 after exposure, whereas BB enhanced vessel permeability only at T7 . At this stage MRT was more efficient at increasing tumor vessel permeability (BB vs untreated: +19.1%; P=.0467; MRT vs untreated: +44.8%; P<.0001), and its effects lasted until T14 (MRT vs BB, +22.6%; P=.0199). We also showed that MRT was more efficient at targeting highly oxygenated (high blood volume and flow) and more proliferative parts of the tumor than BB., Conclusions: Microbeam radiation therapy-induced increased tumor vascular permeability is: (1) significantly greater; (2) earlier and more prolonged than that induced by BB irradiation, especially in highly proliferative tumor areas; and (3) targets all tumor areas discriminated by physiologic characteristics, including those not damaged by homogeneous irradiation., (Copyright © 2017 Elsevier Inc. All rights reserved.)- Published
- 2017
- Full Text
- View/download PDF
18. Synchrotron microbeam irradiation induces neutrophil infiltration, thrombocyte attachment and selective vascular damage in vivo.
- Author
-
Brönnimann D, Bouchet A, Schneider C, Potez M, Serduc R, Bräuer-Krisch E, Graber W, von Gunten S, Laissue JA, and Djonov V
- Subjects
- Animal Fins blood supply, Animal Fins radiation effects, Animal Fins ultrastructure, Animals, Connective Tissue pathology, Hemostasis, Inflammation pathology, Perfusion, Zebrafish, Blood Platelets radiation effects, Blood Vessels pathology, Neutrophil Infiltration radiation effects, Platelet Adhesiveness radiation effects, Synchrotrons
- Abstract
Our goal was the visualizing the vascular damage and acute inflammatory response to micro- and minibeam irradiation in vivo. Microbeam (MRT) and minibeam radiation therapies (MBRT) are tumor treatment approaches of potential clinical relevance, both consisting of parallel X-ray beams and allowing the delivery of thousands of Grays within tumors. We compared the effects of microbeams (25-100 μm wide) and minibeams (200-800 μm wide) on vasculature, inflammation and surrounding tissue changes during zebrafish caudal fin regeneration in vivo. Microbeam irradiation triggered an acute inflammatory response restricted to the regenerating tissue. Six hours post irradiation (6 hpi), it was infiltrated by neutrophils and fli1a(+) thrombocytes adhered to the cell wall locally in the beam path. The mature tissue was not affected by microbeam irradiation. In contrast, minibeam irradiation efficiently damaged the immature tissue at 6 hpi and damaged both the mature and immature tissue at 48 hpi. We demonstrate that vascular damage, inflammatory processes and cellular toxicity depend on the beam width and the stage of tissue maturation. Minibeam irradiation did not differentiate between mature and immature tissue. In contrast, all irradiation-induced effects of the microbeams were restricted to the rapidly growing immature tissue, indicating that microbeam irradiation could be a promising tumor treatment tool.
- Published
- 2016
- Full Text
- View/download PDF
19. Synchrotron microbeam radiation therapy induces hypoxia in intracerebral gliosarcoma but not in the normal brain.
- Author
-
Bouchet A, Lemasson B, Christen T, Potez M, Rome C, Coquery N, Le Clec'h C, Moisan A, Bräuer-Krisch E, Leduc G, Rémy C, Laissue JA, Barbier EL, Brun E, and Serduc R
- Subjects
- Animals, Brain Neoplasms blood supply, Brain Neoplasms metabolism, Gliosarcoma blood supply, Gliosarcoma metabolism, Glucose Transporter Type 1 analysis, Magnetic Resonance Imaging, Rats, Brain radiation effects, Brain Neoplasms radiotherapy, Gliosarcoma radiotherapy, Oxygen blood, Synchrotrons, X-Ray Therapy methods
- Abstract
Purpose: Synchrotron microbeam radiation therapy (MRT) is an innovative irradiation modality based on spatial fractionation of a high-dose X-ray beam into lattices of microbeams. The increase in lifespan of brain tumor-bearing rats is associated with vascular damage but the physiological consequences of MRT on blood vessels have not been described. In this manuscript, we evaluate the oxygenation changes induced by MRT in an intracerebral 9L gliosarcoma model., Methods: Tissue responses to MRT (two orthogonal arrays (2 × 400Gy)) were studied using magnetic resonance-based measurements of local blood oxygen saturation (MR_SO2) and quantitative immunohistology of RECA-1, Type-IV collagen and GLUT-1, marker of hypoxia., Results: In tumors, MR_SO2 decreased by a factor of 2 in tumor between day 8 and day 45 after MRT. This correlated with tumor vascular remodeling, i.e. decrease in vessel density, increases in half-vessel distances (×5) and GLUT-1 immunoreactivity. Conversely, MRT did not change normal brain MR_SO2, although vessel inter-distances increased slightly., Conclusion: We provide new evidence for the differential effect of MRT on tumor vasculature, an effect that leads to tumor hypoxia. As hypothesized formerly, the vasculature of the normal brain exposed to MRT remains sufficiently perfused to prevent any hypoxia., (Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.